CAPTAIN STUDY: ASSOCIATION OF MODERATE AND SEVERE ASTHMA EXACERBATIONS WITH LUNG FUNCTION AND PATIENT-REPORTED OUTCOMES IN A LARGE RANDOMIZED PHASE III CLINICAL TRIAL

被引:0
|
作者
Sule, Neal
Fowler, Andrew
Kerstjens, Huib
Kerwin, Edward
Lee, Laurie
Nathan, Robert
Oppenheimer, John
Pavord, Ian
Peachey, Guy
Tabberer, Maggie
Zarankaite, Agne
Manning, Michael
Millard, Mark
Mannino, David
Hanania, Nicola
机构
关键词
D O I
10.1016/j.chest.2020.08.072
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:35A / 38A
页数:4
相关论文
共 50 条
  • [31] Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
    Strand, Vibeke
    Gossec, Laure
    Proudfoot, Clare W. J.
    Chen, Chieh-I
    Reaney, Matthew
    Guillonneau, Sophie
    Kimura, Toshio
    van Adelsberg, Janet
    Lin, Yong
    Mangan, Erin K.
    van Hoogstraten, Hubert
    Burmester, Gerd R.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [32] Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
    Vibeke Strand
    Laure Gossec
    Clare W. J. Proudfoot
    Chieh-I Chen
    Matthew Reaney
    Sophie Guillonneau
    Toshio Kimura
    Janet van Adelsberg
    Yong Lin
    Erin K. Mangan
    Hubert van Hoogstraten
    Gerd R. Burmester
    Arthritis Research & Therapy, 20
  • [33] Patient-Reported Outcomes in the Acute Phase of the Randomized Hypofractionated Irradiation for Prostate Cancer (HYPRO) Trial
    Sinzabakira, Felix
    Heemsbergen, Wilma D.
    Pos, Floris J.
    Incrocci, Luca
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (04): : 870 - 879
  • [34] The FamilyTalk randomized controlled trial: patient-reported outcomes in clinical genetic sequencing for colorectal cancer
    Sukh Makhnoon
    Deborah J. Bowen
    Brian H. Shirts
    Stephanie M. Fullerton
    Eric B. Larson
    James D. Ralston
    Kathleen A. Leppig
    David R. Crosslin
    David Veenstra
    Gail P. Jarvik
    Cancer Causes & Control, 2021, 32 : 483 - 492
  • [35] Dupilumab Improves Patient-Reported Outcomes In Uncontrolled Persistent Asthma: Results From A Phase 2b Clinical Trial
    Chanez, P.
    Corren, J.
    Castro, M.
    Fabbri, L.
    Joish, V. N.
    Evans, R. E.
    Graham, N. M. H.
    Mastey, V.
    Abbe, A.
    Taniou, C.
    Mahajan, S.
    Teper, A.
    Pirozzi, G.
    Eckert, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [36] The FamilyTalk randomized controlled trial: patient-reported outcomes in clinical genetic sequencing for colorectal cancer
    Makhnoon, Sukh
    Bowen, Deborah J.
    Shirts, Brian H.
    Fullerton, Stephanie M.
    Larson, Eric B.
    Ralston, James D.
    Leppig, Kathleen A.
    Crosslin, David R.
    Veenstra, David
    Jarvik, Gail P.
    CANCER CAUSES & CONTROL, 2021, 32 (05) : 483 - 492
  • [37] When Using Patient-Reported Outcomes in Clinical Practice, the Measure Matters: A Randomized Controlled Trial
    Snyder, Claire F.
    Herman, Joseph M.
    White, Sharon M.
    Luber, Brandon S.
    Blackford, Amanda L.
    Carducci, Michael A.
    Wu, Albert W.
    JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (05) : E299 - E306
  • [38] Patient-reported symptoms and signs in patients with moderate-severe plaque psoriasis treated with guselkumab or adalimumab: Results from VOYAGE 1, a phase III clinical trial
    Blauvelt, Andrew
    Papp, Kim
    Griffiths, Christopher E. M.
    Han, Chenglong
    Randazzo, Bruce
    Wasfi, Yasmine
    Li, Shu
    Kimball, Alexa B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB191 - AB191
  • [39] Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
    Vibeke Strand
    David Fiorentino
    ChiaChi Hu
    Robert M Day
    Randall M Stevens
    Kim A Papp
    Health and Quality of Life Outcomes, 11
  • [40] Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
    Strand, Vibeke
    Fiorentino, David
    Hu, ChiaChi
    Day, Robert M.
    Stevens, Randall M.
    Papp, Kim A.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11